Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Kulp

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Biophysicist (Rockville, Md.)|February 7, 2022
PyRosetta Jupyter Notebooks Teach Biomolecular Structure Prediction and DesignKathy H Le, Jared Adolf-Bryfogle, Jason C Klima, et al.
Nature Medicine|February 19, 2020
Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Vaccine|May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivoKevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Cell|September 10, 2016
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing AntibodiesBryan Briney, Devin Sok, Joseph G Jardine, et al.
Emerging Microbes & Infections|January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primatesAmi Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Biophysicist (Rockville, Md.)|February 7, 2022
PyRosetta Jupyter Notebooks Teach Biomolecular Structure Prediction and DesignKathy H Le, Jared Adolf-Bryfogle, Jason C Klima, et al.
Nature Medicine|February 19, 2020
Engineered immunogen binding to alum adjuvant enhances humoral immunityTyson J Moyer, Yu Kato, Wuhbet Abraham, et al.
Vaccine|May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivoKevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Cell|September 10, 2016
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing AntibodiesBryan Briney, Devin Sok, Joseph G Jardine, et al.
Emerging Microbes & Infections|January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primatesAmi Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Pageof 8